Neuren previously reported positive results in the Magel-2 mouse model of Prader-Willi syndrome, in which treatment with NNZ-2591 for 6 weeks normalized fat mass, insulin levels, IGF1 levels and all behavioural deficits.
And this is why I expect this particular trial to be keenly watched...
Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.31 |
Change
-0.440(2.79%) |
Mkt cap ! $1.934B | |||
| Open | High | Low | Value | Volume |
| $15.80 | $15.80 | $15.19 | $4.985M | 321.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 352 | $15.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.31 | 99 | 8 |
View Market Depth
| Last trade - 14.08pm 23/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |